Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
About Tender
💉 Procurement Opportunity For Insulin Degludec And Insulin Aspart Solutions 💉 The Ministry Of Railways, Specifically The Central Government Ministry/Department, Is Seeking Bids For The Supply Of Insulin Degludec And Insulin Aspart Solutions. The Solution Provided In A 3ml Penfill Cartridge Contains 100 Units Of Insulin Degludec And Insulin Aspart, With 70% Being Soluble Insulin Degludec And 30% Soluble Insulin Aspart, Equivalent To 2.56mg And 1.05mg Of Salt Free Anhydrous Insulin Degludec And Insulin Aspart, Respectively. 📅 Bid Submission Deadline: May 30, 2024, 10:30 Am Interested Bidders Are Requested To Submit Their Proposals By The Specified Deadline, Ensuring They Meet All The Technical And Financial Requirements As Outlined In The Tender Document. Keywords: Insulin Degludec, Insulin Aspart, Insulin Solution, Procurement, Ministry Of Railways, Central Government, Diabetes Care, Tender, Bid Submission| Particulars | Details |
|---|---|
| Title |
Insulin Degludec / Insulin Aspart (R Dna Origin) Solution For Subcutaneous Injection. 1ml Of The Solution Contains 100 Units Insulin Degludec And Insulin Aspart (70 Percent Soluble Insulin Degludec And 30 Percent Soluble Insulin Aspart) Equivalent To 2.56mg Salt Free Anhydrous Insulin Degludec And 1.05mg Salt Free Anhydrous Insulin Aspart In 3ml Penfill Cartridge.
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106351423 |
|
Reference Number |
08245042C |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | |
| Place | Bilaspur |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/052024/106351423/viewNitPdf_4577811.pdf |
| Start Date | May 20, 2024 22:34 |
| End Date |
Expired
30/05/2024
Expired 767 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Insulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
Read moreInsulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreSupply of srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSrph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSrph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreof your Industry type